Electronic Health Reporter

APRIL 4, 2019

Protein-based drugs are a quickly growing pharmaceutical sector, providing treatments for cancer and autoimmune diseases, among others. The goal is the development of compounds that have a stability measured in years. Though there are many factors that can negatively affect the successful development of protein drugs, it is […].

Pharmaceuticals 79

Pharmaceuticals 79

Digital Health Global

JUNE 6, 2023

Then, physicians can determine if a prescription was filled and have the option to develop a personalized care plan based on the data provided. “As Via the PhilRx Patient Access Platform, patients can now access Teva Pharmaceuticals’ Digihaler® family of inhalers SAN FRANCISCO–(BUSINESS WIRE)– Phil Inc.,

Pharmaceuticals 88

Pharmaceuticals Life Science EMR Digital Health 88

Digital Health Global

FEBRUARY 24, 2023

The Digihaler System is the first and only smart inhaler system with built-in sensors that provide objective inhaler event data to help patients and their doctors support asthma management and develop personalized treatment plans. –(BUSINESS WIRE)–Teva Pharmaceuticals USA, Inc., affiliate of Teva Pharmaceutical Industries Ltd.

Pharmaceuticals 88

Pharmaceuticals Digital Health 88

Healthcare IT Today

JANUARY 8, 2024

Health Economics Outcomes Research (HEOR) will become more common in decentralized clinical trials (DCTs). Jane Reed, Director of Life Sciences at Linguamatics, an IQVIA company Pharmaceutical developers have always prioritized drug safety. In fact, we got so many that we had to narrow them down to just the best and most interesting.

Health IT 92

Health IT Drug Development Pharmaceuticals BioTech 92